Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy? - Concepedia

Concepedia

Publication | Open Access

Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia: Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy?

DOI Full Paper Access

31

Citations

36

References

2023

Year

Sining Liu, Xinyue Zhang, Haiping Dai, Wei Cui, Jia Yin, Zheng Li, Yang Xiao, Chunxiu Yang, Shengli Xue, Huiying Qiu,

Blood Cancer Journal

References

	Year	Citations

Page 1